Tilray Brands Inc (2HQ.DE)

Healthcare | Drug Manufacturers Specialty Generic
Latest reporting period: 2026-02-28

Latest Quarter

2026-02-28

Revenue

$207M

Net Income

$0.0

Operating Margin

-12.8%

Free Cash Flow

-$175M

Debt / Assets

29.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Tilray Brands Inc (2HQ.DE).
Income Statement (Quarterly) 2026-02-28 2025-11-30 2025-08-31 2025-05-31
Revenue 206,732,000 303,852,928 287,778,953 308,104,681
Cost of Revenue 151,778,000 223,530,769 208,837,236 215,299,355
Gross Profit 54,954,000 80,322,159 78,941,717 92,805,326
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 60,845,000 102,078,725 88,423,954 81,724,892
Operating Expenses 81,340,000 111,445,476 76,068,062 2,074,228,475
Operating Income -26,386,000 -31,123,317 2,873,654 -1,981,423,149
Interest Expense 0 7,507,370 9,197,893 5,442,105
Income Before Tax -23,259,000 -55,827,511 -1,060,450 -1,911,511,441
Income Tax Expense 1,974,000 4,953,691 -3,138,767 -171,718,600
Net Income 0 -62,767,708 -442,312 -1,746,516,571
Per Share
EPS 0.00 -0.57 0.00 -17.80
EPS Diluted 0.00 0.00 0.00 0.00